These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10527393)

  • 1. Comparison of crossmatch results obtained by ELISA, flow cytometry, and conventional methodologies.
    Pelletier RP; Adams PW; Hennessy PK; Orosz CG
    Hum Immunol; 1999 Sep; 60(9):855-61. PubMed ID: 10527393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Cytotoxic Flow Cytometric Cross Match With Complement Dependent Lymphocytotoxicity and Flow Cytometric Cross Match in Renal Transplant Patients.
    Bilgen T; Canbakan M; Şahin G; Titiz Mİ
    Transplant Proc; 2019 May; 51(4):1021-1023. PubMed ID: 31101163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic impact of flow cytometry crossmatching in primary cadaveric kidney and simultaneous pancreas-kidney transplant recipients.
    Pelletier RP; Orosz CG; Adams PW; Bumgardner GL; Davies EA; Elkhammas EA; Henry ML; Ferguson RM
    Transplantation; 1997 Jun; 63(11):1639-45. PubMed ID: 9197360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DSA-FXM: Accelerated Donor-specific Flow Crossmatch Discriminating Class I and II Antibody Specifically and Only to Donor HLA for Determining True Incompatibility.
    Chen G; Lin L; Tyan DB
    Transplantation; 2020 Apr; 104(4):813-822. PubMed ID: 31385929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplant immuno-diagnostics: crossmatch and antigen detection.
    South AM; Grimm PC
    Pediatr Nephrol; 2016 Jun; 31(6):897-905. PubMed ID: 26139577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble HLA antigens and ELISA--a new technology for crossmatch testing.
    Buelow R; Chiang TR; Monteiro F; Cornejo MC; Ellingson L; Claas F; Gaber O; Gelder F; Kotb M; Orosz C
    Transplantation; 1995 Dec; 60(12):1594-9. PubMed ID: 8545896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching.
    Alheim M; Paul PK; Hauzenberger DM; Wikström AC
    Hum Immunol; 2015 Nov; 76(11):849-57. PubMed ID: 26429307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes.
    Gandhi MJ; DeGoey SR; Bundy K; Kremers WK; Knauer R; Pereira N; Edwards B; Kushwaha S; Daly RC
    Transplant Proc; 2011 Dec; 43(10):3840-6. PubMed ID: 22172857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic flow-cytometric crossmatches (flow-tox): a comparison with conventional cytotoxicity crossmatch techniques.
    Wetzsteon PJ; Head MA; Fletcher LM; Lye WC; Norman DJ
    Hum Immunol; 1992 Oct; 35(2):93-9. PubMed ID: 1286980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure.
    Altermann WW; Seliger B; Sel S; Wendt D; Schlaf G
    Histol Histopathol; 2006 Oct; 21(10):1115-24. PubMed ID: 16835834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study.
    Buelow R; Mercier I; Glanville L; Regan J; Ellingson L; Janda G; Claas F; Colombe B; Gelder F; Grosse-Wilde H
    Hum Immunol; 1995 Sep; 44(1):1-11. PubMed ID: 8522449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens.
    Reinsmoen NL; Patel J; Mirocha J; Lai CH; Naim M; Ong G; Wang Q; Zhang X; Liou F; Yu Z; Kobashigawa J
    J Heart Lung Transplant; 2016 Feb; 35(2):165-72. PubMed ID: 26683810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
    Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
    Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
    Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.